BIMSA >
BIMSA Lecture
The epigentic dysregulation in pancreatic cancer : from tumor cells to tumor microenviroment
The epigentic dysregulation in pancreatic cancer : from tumor cells to tumor microenviroment
组织者
演讲者
薛婧
时间
2024年11月29日 10:00 至 11:00
地点
A3-4-101
线上
Zoom 388 528 9728
(BIMSA)
摘要
The tumor microenvironment (TME) in pancreatic ductal adenocarcinoma (PDAC) involves a significant accumulation of cancer-associated fibroblasts (CAFs) as part of the host response to tumor cells. The origins and functions of transcriptionally diverse CAF populations in PDAC remain poorly understood. Tumor cell-intrinsic genetic mutations and epigenetic dysregulation may reshape the TME; however, their impacts on CAF heterogeneity remains elusive. SETD2, a histone H3K36 trimethyl-transferase, functions as a tumor suppressor. Through single-cell RNA sequencing, we identify a novel lipid-laden CAF subpopulation marked by ABCA8a in Setd2-deficient pancreatic tumors. Our findings reveal that tumor-intrinsic SETD2 loss unleashes BMP2 signaling via ectopic gain of H3K27Ac, leading to CAFs differentiation towards lipid-rich phenotype. Lipid-laden CAFs then enhance tumor progression by providing lipids for mitochondrial oxidative phosphorylation via ABCA8a transporter. Together, our study links CAF heterogeneity to epigenetic dysregulation in tumor cells, highlighting a previously unappreciated metabolic interaction between CAFs and pancreatic tumor cells.
演讲者介绍
上海交通大学医学院及肿瘤系统医学全国重点实验室研究员,博导,国家优青(肿瘤学,2020年)。近10年来带领团队聚焦胰腺炎症和肿瘤,从表观遗传调控、微环境重塑等方面展开相关病理机制和靶向策略研究。近5年以通讯作者发表研究成果于Cancer Cell,Gut (2024, 2020), Advanced Science(2024,2023)和 Cell Reports 等国际权威杂志20余篇。主持国家自然科学基金 5 项(优青 1 项、面上 3 项、青年 1 项),上海市东方学者、青年拔尖人才项目。获得华夏青年医学科技奖(2024年)、上海医学科技奖一等奖 (2022年度,第二完成人)、以及美国、国际胰腺协会青年学者奖。现任中华医学会肿瘤学分会青年委员、中国生理学会基质生物学专业委员会委员、以及Cellular oncology副主编、Journal of Pancreatology编委等。